Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Transplantation | 6 | 2014 | 154 | 0.870 |
Why?
|
| Wound Healing | 8 | 2016 | 193 | 0.610 |
Why?
|
| Epidermis | 4 | 2013 | 35 | 0.500 |
Why?
|
| Bandages, Hydrocolloid | 1 | 2013 | 1 | 0.400 |
Why?
|
| Re-Epithelialization | 1 | 2013 | 4 | 0.400 |
Why?
|
| Skin | 2 | 2014 | 422 | 0.390 |
Why?
|
| Microsurgery | 1 | 2012 | 54 | 0.350 |
Why?
|
| Wound Infection | 3 | 2016 | 29 | 0.350 |
Why?
|
| Regeneration | 1 | 2012 | 125 | 0.330 |
Why?
|
| Staphylococcal Infections | 3 | 2016 | 130 | 0.320 |
Why?
|
| Swine | 8 | 2016 | 394 | 0.310 |
Why?
|
| Keratinocytes | 4 | 2016 | 71 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 3 | 2016 | 801 | 0.230 |
Why?
|
| End Stage Liver Disease | 1 | 2022 | 33 | 0.180 |
Why?
|
| Cell Movement | 2 | 2014 | 480 | 0.180 |
Why?
|
| Cicatrix | 2 | 2014 | 62 | 0.180 |
Why?
|
| Liver Transplantation | 1 | 2022 | 220 | 0.150 |
Why?
|
| Minocycline | 2 | 2016 | 28 | 0.150 |
Why?
|
| Gentamicins | 2 | 2016 | 24 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2014 | 6 | 0.130 |
Why?
|
| Burns | 1 | 2016 | 45 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2016 | 73 | 0.110 |
Why?
|
| Animals | 11 | 2016 | 21333 | 0.110 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 44 | 0.110 |
Why?
|
| Administration, Topical | 4 | 2016 | 50 | 0.110 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 29 | 0.110 |
Why?
|
| Ketamine | 1 | 2014 | 39 | 0.110 |
Why?
|
| Wound Closure Techniques | 1 | 2013 | 5 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 148 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 235 | 0.090 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 33 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 250 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 113 | 0.080 |
Why?
|
| Inflammation | 1 | 2016 | 1187 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2009 | 65 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 240 | 0.080 |
Why?
|
| Female | 8 | 2016 | 34031 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 234 | 0.070 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2010 | 179 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2016 | 5791 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 195 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 325 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2010 | 321 | 0.070 |
Why?
|
| Random Allocation | 2 | 2016 | 200 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 2293 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2022 | 30 | 0.050 |
Why?
|
| Living Donors | 1 | 2022 | 79 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2022 | 63 | 0.040 |
Why?
|
| Sus scrofa | 2 | 2013 | 30 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2188 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 159 | 0.030 |
Why?
|
| Debridement | 1 | 2016 | 35 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 132 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 180 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 91 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2014 | 17 | 0.030 |
Why?
|
| Sodium | 1 | 2014 | 59 | 0.030 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 23 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 71 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 422 | 0.030 |
Why?
|
| Skin, Artificial | 1 | 2014 | 7 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 2014 | 16 | 0.030 |
Why?
|
| Elasticity | 1 | 2014 | 45 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 62 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2014 | 110 | 0.030 |
Why?
|
| Biological Transport | 1 | 2014 | 292 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 135 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 624 | 0.020 |
Why?
|
| ras Proteins | 1 | 2013 | 76 | 0.020 |
Why?
|
| Actins | 1 | 2014 | 264 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 233 | 0.020 |
Why?
|
| Humans | 5 | 2022 | 65142 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 491 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2014 | 351 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 213 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2011 | 41 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2011 | 128 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 1994 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 1480 | 0.020 |
Why?
|
| Occlusive Dressings | 1 | 2009 | 4 | 0.020 |
Why?
|
| Streptomycin | 1 | 2009 | 14 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2009 | 17 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 32 | 0.020 |
Why?
|
| Penicillins | 1 | 2009 | 32 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 450 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1036 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 602 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 286 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 152 | 0.020 |
Why?
|
| Insulin | 1 | 2010 | 695 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 17359 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 3762 | 0.010 |
Why?
|
| Male | 1 | 2014 | 31056 | 0.010 |
Why?
|